Ultragenyx Pharmaceutical (RARE) Inventory (2017 - 2026)

Ultragenyx Pharmaceutical (RARE) has 10 years of Inventory data on file, last reported at $55.0 million in Q1 2026.

• Inventory for Q1 2026 came in at $55.0 million, up 19.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.0 million (up 19.48% YoY), and the FY2025 annual result was $52.0 million, up 15.56% from the prior year.
• Inventory advanced to $55.0 million in Q1 2026 per RARE's latest filing, from $52.0 million in the prior quarter.
• Over five years, Inventory peaked at $55.0 million in Q1 2026 and troughed at $17.8 million in Q1 2022.
• A 5-year average of $36.7 million and a median of $35.9 million in 2024 frame the typical range for Inventory.
• The sharpest annual moves came in 2022 and 2025: Inventory soared 64.91% in 2022, then rose 15.56% in 2025.
• A 5-year view of Inventory shows it stood at $26.8 million in 2022, then advanced by 26.91% to $34.0 million in 2023, then soared by 32.47% to $45.0 million in 2024, then advanced by 15.56% to $52.0 million in 2025, then climbed by 5.77% to $55.0 million in 2026.
• Business Quant data shows RARE's Inventory at $55.0 million in Q1 2026, $52.0 million in Q4 2025, and $52.2 million in Q3 2025.